4//SEC Filing
Linscott Walt Addison 4
Accession 0001213900-20-004341
CIK 0001638381other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:45 PM ET
Size
5.3 KB
Accession
0001213900-20-004341
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-17+90,000→ 90,000 totalExercise: $0.43Exp: 2027-02-17→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 17, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through February 17, 2023.
Documents
Issuer
Intec Pharma Ltd.
CIK 0001638381
Entity typeother
Related Parties
1- filerCIK 0001648585
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 9:45 PM ET
- Size
- 5.3 KB